Pieter Ruytinx

Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes

Rik Janssens, Anneleen Mortier, Daiane Boff et al. · Biochemical Pharmacology · 2017 · 45 citations

Inflammation, Cytokine, Molecular Immunology +11

CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis

Mieke Gouwy, Pieter Ruytinx, Egle Radice et al. · PLoS ONE · 2016 · 37 citations · Full text

Chemokine Biology, Immunology, Cxcl4-treated Imddc +18

Intravital Microscopic Evaluation of the Effects of a CXCR2 Antagonist in a Model of Liver Ischemia Reperfusion Injury in Mice

Thiago Henrique Caldeira de Oliveira, Pedro Elias Marques, Fariba Poosti et al. · Frontiers in Immunology · 2018 · 30 citations · Full text

Monocytes from patients with Primary Ciliary Dyskinesia show enhanced inflammatory properties and produce higher levels of pro-inflammatory cytokines

Maaike Cockx, Mieke Gouwy, Pieter Ruytinx et al. · Scientific Reports · 2017 · 17 citations · Full text

Chronic Inflammatory Diseases, Chemokine Biology, Inflammatory Lung Disease +23

Antibodies Against Three Novel Peptides in Early Axial Spondyloarthritis Patients From Two Independent Cohorts

Dana H.F. Quaden, Patrick Vandormael, Pieter Ruytinx et al. · Arthritis & Rheumatology · 2020 · 11 citations · Full text